Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy

National Medical Journal of China

Volumn 87, Issue 18, 2007, Pages 1230-1233

  Chen, Hai Bing ^a   Jia, Wei Ping ^a   Lu, Jun Xi ^a   Bao, Yu Qian ^a   Li, Qing ^a   Lu, Feng Di ^a   Lu, Wei ^a   Yu, Hao Yong ^a   Xiang, Kun San ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Albuminuria; Diabetic nephropathies; Pigment epithelium derived factor

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PIGMENT EPITHELIUM DERIVED FACTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; TURBIDIMETRY; URINARY EXCRETION;

AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; NERVE GROWTH FACTORS; SERPINS;

EID: 34447579254     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414: 813-820.
2. Tombran-Tink J, Shivaram SM, Chader GJ, et al. Expression, secretion, and age-related downregulation of pigment epitheliumderived factor, a serpin with neurotrophic activity. J Neurosci, 1995, 15: 4992-5003.
3. Wang JJ, Zhang SX, Lu K, et al. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes, 2005, 54: 243-250.
4. Boehm BO, Lang G, Volpert O, et al. Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia, 2003, 46: 394-400.
5. Duh EJ, Yang HS, Haller JA, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol, 2004, 137: 668-674.
6. Tong JP, Chan WM, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol, 2006, 141: 456-462.
7. Wang JJ, Zhang SX, Mott R, et al. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities. Diabetes, 2006, 55: 1678-1685.
8. Yamagishi SI, Nakamura K, Matsui T, et al. Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor (VEGF) expression. J Biol Chem, 2006, 281: 20213-20220.
9. Yamagishi S, Nakamura K, Ueda S, et al. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res, 2005, 320: 437-445.
10. Yamagishi S, Inagaki Y, Nakamura K, et al. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J Mol Cell Cardiol, 2004, 37: 497-506.
11. Tsao YP, Ho TC, Chen SL, et al. Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. Life Sci, 2006, 79: 545-550.
12. Tushuizen ME, Nieuwland R, Scheffer PG, et al. Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy men. J Thromb Haemost, 2006, 4: 1003-1010.
13. Dalla Vestra M, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol, 2005, 16 (Suppl 1: S78-82.
14. Gomes MB, Nogueira VG. Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res Clin Pract, 2004, 66: 31-39.
15. Yoshida T, Yamagishi S, Nakamura K, et al. Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced c-reactive protein expression in hepatoma cells by suppressing Rac-1 activation. FEBS Lett, 2006, 580: 2788-2796.
16. Yoshida T, Yamagishi SI, Nakamura K, et al. Pigment epithelium-derived factor (PEDF) blocks the interleukin-6 signaling to C-reactive protein expression in Hep3B cells by suppressing Rac-1 activation. Life Sci, 2006, 79: 1981-1987.